| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |